Important safety warnings seek urgent medical attention if you experience: Severe or persistent abdominal pain, which may radiate to the back this could indicate pancreatitis , a serious but rare risk associated with GLP-1based therapies as a class [16] [17] Right upper quadrant pain, fever, or jaundice these may suggest gallbladder disease , another class-associated risk Signs of dehydration (dizziness, reduced urine output, extreme thirst) resulting from severe vomiting or diarrhoea, which can affect kidney function Pregnancy and breastfeeding: Use of GLP-1based therapies and related investigational agents is not recommended during pregnancy or breastfeeding
advise maintaining indoor RH ~4050%, fixing moisture intrusions, HEPA vacuuming dust, servicing/cleaning HVAC and ducts, and consider referral to qualified mold assessment/remediation when indicated
Take the missed dose within 3 days (72 hours) of your scheduled injection day
Genome-wide chromatin immunoprecipitation profiling of Sox2 downstream targets in ESCs surprisingly showed that one-half of all Sox2/Oct/Nanog-bound genes represent CG-rich developmental TFs (Kim et al., 2008)